Sign in

Cirrhosis and the patient with liver disease

Endocrine, renal, hepatic and metabolic·~5 min read· Physician-reviewed✓ Sourced · 6

Stem

A 58-year-old man, 76 kg, with alcohol-related cirrhosis is referred for elective repair of a symptomatic umbilical hernia. He has moderate ascites on diuretics, mild confusion treated with lactulose, and exertional dyspnea. Labs: bilirubin 2.6 mg/dL, albumin 2.8 g/dL, INR 1.8, creatinine 1.3 mg/dL, sodium 131, platelets 68,000. Room-air SpO2 is 93%.

Question

Should he have this operation now, and if he does, how will you plan the anesthetic?

Ideal answer

HeadlineNot now: Child C, MELD around 20, so I defer this elective repair, agree it with surgeon and hepatologist, and refer him to a transplant center.

  1. MELD and Child-Pugh first: Child A or MELD under 10 tolerates elective surgery; Child C or MELD above 20, only urgent, life-saving surgery.1 Ascites, encephalopathy, bilirubin 2.6, albumin 2.8, INR 1.8 make him Child C.
  2. If urgent, optimize first: ascites, encephalopathy, renal function, electrolytes, nutrition; dyspnea and low saturation mean an echo for portopulmonary hypertension and hepatopulmonary syndrome.
  3. INR left alone, because it overstates bleeding risk in rebalanced hemostasis; bleeding treated by viscoelastic testing.
  4. Liver-independent drugs: cisatracurium and remifentanil, all else reduced, titrated, no benzodiazepines. Tense ascites and varices: full stomach, rapid sequence, gentle orogastric tube.

Watch for: hepatic blood flow: MAP and cardiac output up; no hypotension, hypoxia or high airway pressures.

Breaking down the answer

  • Decide whether to operate — perioperative mortality tracks severity, and the examiner grades judgment about proceeding. Child-Pugh uses bilirubin, albumin, INR, ascites and encephalopathy; MELD uses bilirubin, INR, creatinine and sodium and predicts 30- and 90-day surgical mortality.
  • The mortality numbers — risk climbs steeply through the teens. Abdominal surgery: Child A ~10%, B ~30%, C ~76–82% in older series;2 MELD 12–15 carries about 25% and 16–20 about 44% 30-day mortality.3
  • Rebalanced hemostasis — pro- and anticoagulants both fall; INR overstates bleeding risk, and they also thrombose. INR thresholds are not evidence-based and plasma raises portal pressure; for bleeding or high-risk procedures: fibrinogen above 120 mg/dL, platelets above 50,000, by TEG or ROTEM.4
  • Hyperdynamic circulation — high cardiac output and low SVR from nitric oxide and splanchnic vasodilation blunt vasoconstrictor response, so I start norepinephrine and vasopressin early.
  • Lungs — hepatopulmonary syndrome causes intrapulmonary shunting, hypoxemia and platypnea; oxygen helps. In portopulmonary hypertension, a mean PA pressure above 35 mmHg needs vasodilator therapy before transplant, and 45 mmHg or more is an absolute contraindication;5 I avoid hypoxia, hypercarbia and acidosis.
  • Ascites — I drain large ascites before induction when it impairs ventilation; above 5 L removed, albumin 6–8 g per liter prevents post-paracentesis circulatory dysfunction.6
  • Drugs — a larger volume of distribution and lower albumin mean a normal or larger initial dose with prolonged duration; benzodiazepines precipitate encephalopathy.3

Follow-up question

Three weeks later the hernia incarcerates and he comes for urgent repair. After 2 L of ascites drains through the hernia sac, the MAP falls to 55 and the field begins to ooze. What do you do?

Follow-up answer

HeadlineVasodilation from the loss of abdominal pressure in a hyperdynamic patient, plus a bleeding problem not yet characterized; I tell the surgeon.

Albumin and norepinephrine, vasopressin if needed; a gas, hemoglobin, ionized calcium and TEG. Low fibrinogen gets cryoprecipitate; weak clot strength, platelets; plasma only for a prolonged R time with active bleeding, because large-volume plasma raises portal pressure and worsens bleeding.4 I reassess pressure and the field. Postoperatively I watch for hepatorenal syndrome, treated with albumin and a vasoconstrictor such as terlipressin or norepinephrine, and for encephalopathy, treated with lactulose and rifaximin.

Pitfalls that cost points

  • Treating low SVR with fluid alone.
  • Correcting a pre-procedure INR with plasma.

Rapid-fire

Q: Why is cisatracurium preferred? A: Hofmann elimination is independent of the liver and kidney; rocuronium and vecuronium are prolonged.

Q: Why are these patients hyponatremic? A: Splanchnic vasodilation triggers ADH release and water retention; I correct no faster than 8 mEq/L per day because of osmotic demyelination.

Q: Why does the volatile choice matter little? A: Sevoflurane, desflurane and isoflurane all maintain hepatic blood flow; halothane is the one that reduces it.

Q: Is acetaminophen safe? A: Yes, at a reduced ceiling of about 2–3 g per day,3 and it is better than NSAIDs, which precipitate renal failure and bleeding.

Numbers to know

Item Value
MELD for elective surgery < 10 acceptable; > 20 defer all but urgent surgery1
Child-Pugh abdominal surgery mortality A ~10%, B ~30%, C ~76–82%2
Albumin with paracentesis 6–8 g per L removed when > 5 L drained6
Fibrinogen target (bleeding or high-risk procedure) > 120 mg/dL; platelets > 50,0004
Portopulmonary hypertension mPAP > 35 treat first; ≥ 45 contraindicates transplant5
Acetaminophen in cirrhosis 2–3 g/day3

Sources

  1. 1.AGA Clinical Practice Update: Surgical risk assessment and perioperative management in cirrhosis (MDedge summary) · American Gastroenterological Association, 2019 · mdedge.comMELD >20 or Child C: postpone all but urgent procedures until after transplant; use multiple scores (CTP, MELD, Mayo).
  2. 2.Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease (Table 2) · Journal of Gastrointestinal Surgery, 2018 · pmc.ncbi.nlm.nih.gov
  3. 3.Liver Cirrhosis Surgical Patient Management - Adult · Auckland District Health Board (NZSG), 2020 · nzsg.org.nzMELD 30-day mortality bands; benzodiazepines raise encephalopathy risk; paracetamol 2–3 g/day.
  4. 4.Coagulation in Cirrhosis (clinical practice update) · American Gastroenterological Association · gastro.org
  5. 5.Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis · Liver Transplantation, 2020 · pmc.ncbi.nlm.nih.govCites ILTS: mPAP >35 treat before transplant; mPAP ≥45 absolute contraindication.
  6. 6.Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome · Cleveland Clinic Journal of Medicine, 2023 · ccjm.orgSummarizes AASLD 2021 guidance on albumin with large-volume paracentesis.

Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.

Found an error or a better way your examiners phrased this? Send feedback on this page.